ICD10 code of WNT4 Deficiency and ICD9 code

ICD-10 Code for WNT4 Deficiency: Q99.8

ICD-9 Code for WNT4 Deficiency: 758.6

WNT4 deficiency is a rare genetic disorder that affects the development of reproductive organs in individuals assigned female at birth. It is caused by mutations in the WNT4 gene, which plays a crucial role in the formation of various tissues and organs during embryonic development.

Individuals with WNT4 deficiency may present with a range of symptoms and variations in the development of their reproductive system. Some common features include underdeveloped or absent ovaries, abnormal development of the uterus and fallopian tubes, and ambiguous genitalia. These variations can lead to infertility, primary amenorrhea (absence of menstruation), and other reproductive challenges.

Diagnosing WNT4 deficiency involves a thorough clinical evaluation, including a detailed medical history, physical examination, and genetic testing. The ICD-10 code Q99.8 is used to classify this condition in the International Classification of Diseases, 10th Revision (ICD-10). This code falls under the category of "Other specified congenital malformations of genital organs" and provides a specific identifier for WNT4 deficiency.

In the previous version of the classification system, the ICD-9 code 758.6 was used to represent WNT4 deficiency. This code was categorized under "Other anomalies of the genital organs" and helped healthcare professionals identify and document the condition.

It is important to note that the transition from ICD-9 to ICD-10 occurred on October 1, 2015, and healthcare providers now primarily use the ICD-10 coding system for diagnostic purposes. The updated classification system allows for more detailed and specific coding, facilitating accurate documentation and improved understanding of various medical conditions.

Proper coding of WNT4 deficiency using the respective ICD-10 (Q99.8) or ICD-9 (758.6) code is essential for medical record keeping, billing, and statistical analysis. These codes enable healthcare professionals, researchers, and policymakers to track the prevalence, incidence, and outcomes of WNT4 deficiency, contributing to the advancement of knowledge and the provision of appropriate care for affected individuals.